#Ok, we, as doctors, are interested in cholesterol counts because they have been shown, time and time again, to correlate with rates of cardiovascular disease, including heart attacks, hospitalization, and mortality rates.  Not only that, but it s been shown in large, controlled trials that lowering levels of LDL cholesterol can reduce cardiac events and mortality..
#(S1 (S (INTJ (UH Ok)) (, ,) (NP (PRP we)) (, ,) (PP (IN as) (NP (NNS doctors))) (, ,) (VP (AUX are) (ADJP (JJ interested) (PP (IN in) (NP (NN cholesterol) (NNS counts)))) (SBAR (IN because) (S (NP (PRP they)) (VP (VP (AUX have) (VP (AUX been) (VP (VBN shown)))) (, ,) (NP (NP (NN time) (CC and) (NN time)) (SBAR (S (ADVP (RB again)) (, ,) (S (VP (TO to) (VP (VB correlate) (PP (IN with) (NP (NP (NNS rates)) (PP (IN of) (NP (JJ cardiovascular) (NN disease))) (, ,) (PP (VBG including) (NP (NP (NN heart) (NNS attacks)) (, ,) (NP (NN hospitalization)) (, ,) (CC and) (NP (NP (NN mortality) (NN rates.)) (CONJP (RB Not) (RB only)) (NP (DT that)))))))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBZ s) (VP (AUX been) (VP (VBN shown) (PP (IN in) (NP (JJ large) (, ,) (JJ controlled) (NNS trials))) (SBAR (IN that) (S (NP (NP (VBG lowering) (NNS levels)) (PP (IN of) (NP (NNP LDL) (NN cholesterol)))) (VP (MD can) (VP (VB reduce) (NP (NP (JJ cardiac) (NNS events)) (CC and) (NP (NN mortality))))))))))) (. .)))))))) (. .)))
#Rule:Nouns
r1doctorsNNS
r1cholesterolNN
r1countsNNS
r1timeNN
r1timeNN
r1ratesNNS
r1diseaseNN
r1heartNN
r1attacksNNS
r1hospitalizationNN
r1mortalityNN
r1ratesNN
r1trialsNNS
r1levelsNNS
r1LDLOrganizationAnnotation
r1cholesterolNN
r1eventsNNS
r1mortalityNN

#Rule:Verbs
r2shownVBN
r2correlateVB
r2includingVBG
r2sVBZ
r2shownVBN
r2loweringVBG
r2reduceVB

#Rule:Adjs
r4interestedJJ
r4cardiovascularJJ
r4largeJJ
r4controlledJJ
r4cardiacJJ

#Rule:Adj-Noun
r5cardiovascularJJdiseaseNN
r5largeJJtrialsNNS
r5controlledJJtrialsNNS
r5loweringVBGlevelsNNS
r5cardiacJJeventsNNS

#Rule:N-HeadNoun
r8cholesterolNNcountsNNS
r8heartNNattacksNNS
r8mortalityNNratesNN
r8LDLOrganizationAnnotationcholesterolNN

#Rule:N-ApposN
r10attacksNNShospitalizationNN

#Rule:HeadNoun-V
r11wePRPareAUX
r11itPRPsVBZ
r11levelsNNSreduceVB

#Rule:V-HeadNoun
r21haveAUXtimeNN
r21reduceVBeventsNNS

#Rule:V-HeadNoun(passive)
r23shownVBNtheyPRP
r23shownVBNitPRP

#Rule:V-ADJ
r25areAUXinterestedJJ

#Rule:PPinNP
r26ratesNNSofINdiseaseNN
r26levelsNNSofINcholesterolNN

#Rule:PPinVP
r30correlateVBwithINratesNNS

#Rule:PPinVP
r32shownVBNinINtrialsNNS

#Rule:PPinS
r36areAUXasINdoctorsNNS

#Rule:PPinADJP
r37interestedJJinINcountsNNS

#Rule:V-IN-V
r43areAUXbecauseINshownVBN
r43shownVBNthatINreduceVB

#It s really just that simple, we want to know cholesterol levels because it helps us treat patients better, and hopefully, keep people alive and healthy longer.  And the evidence backs that up..
#(S1 (S (S (NP (PRP It)) (VP (VBZ s) (ADVP (RB really)) (NP (RB just) (DT that) (NN simple)))) (, ,) (NP (PRP we)) (VP (VBP want) (S (VP (TO to) (VP (VB know) (NP (NN cholesterol) (NNS levels)) (SBAR (IN because) (S (S (NP (PRP it)) (VP (VBZ helps) (S (NP (PRP us)) (VP (VB treat) (NP (NNS patients)) (ADVP (ADVP (RB better)) (, ,) (CC and) (ADVP (RB hopefully))))) (, ,) (S (VP (VB keep) (NP (NNS people)) (NP (ADJP (JJ alive) (CC and) (JJ healthy)) (NN longer.)))))) (CC And) (S (NP (DT the) (NN evidence)) (VP (VBZ backs) (NP (DT that)) (PRT (RP up)))) (. .))))))) (. .)))
#Rule:Nouns
r1simpleNN
r1cholesterolNN
r1levelsNNS
r1patientsNNS
r1peopleNNS
r1longerNN
r1evidenceNN

#Rule:Verbs
r2sVBZ
r2wantVBP
r2knowVB
r2helpsVBZ
r2treatVB
r2keepVB
r2backsVBZ

#Rule:V-PRT
r3backsVBZupRP

#Rule:Adjs
r4aliveJJ
r4healthyJJ

#Rule:Adj-Noun
r5aliveJJlongerNN
r5healthyJJlongerNN

#Rule:N-HeadNoun
r8cholesterolNNlevelsNNS

#Rule:HeadNoun-V
r11wePRPwantVBP
r11itPRPsVBZ
r11itPRPhelpsVBZ
r11usPRPtreatVB
r11evidenceNNbacksVBZ

#Rule:V-HeadNoun
r21sVBZsimpleNN
r21knowVBlevelsNNS
r21treatVBpatientsNNS
r21keepVBpeopleNNS
r21keepVBlongerNN
r21backsVBZthatDT

#Rule:V-HeadNoun
r22helpsVBZusPRP

#Rule:V-V
r44wantVBPknowVB

#Rule:V-ADV
r46sVBZreallyRB
r46treatVBbetterRB
r46treatVBhopefullyRB

#Cholesterol levels can be used with framingham study data (which is essentially the foundation of all risk estimation for cardiac events today) to help predict mortality (usually 5 or 10 year mortality).
#(S1 (S (NP (NN Cholesterol) (NNS levels)) (VP (MD can) (VP (AUX be) (VP (VBN used) (PP (IN with) (NP (NP (NNP framingham) (NN study) (NNS data)) (PRN (-LRB- -LRB-) (SBAR (WHNP (WDT which)) (S (VP (AUX is) (ADVP (RB essentially)) (NP (NP (DT the) (NN foundation)) (PP (IN of) (NP (NP (DT all) (NN risk) (NN estimation)) (PP (IN for) (NP (JJ cardiac) (NNS events))) (NP (NN today)))))))) (-RRB- -RRB-)))) (S (VP (TO to) (VP (VB help) (VP (VB predict) (NP (NP (NN mortality)) (PRN (-LRB- -LRB-) (ADVP (RB usually)) (NP (QP (CD 5) (CC or) (CD 10) (NN year)) (NN mortality)) (-RRB- -RRB-)))))))))) (. .)))
#Rule:Nouns
r1CholesterolNN
r1levelsNNS
r1framinghamLocationAnnotation
r1studyNN
r1dataNNS
r1foundationNN
r1riskNN
r1estimationNN
r1eventsNNS
r1todayNN
r1mortalityNN
r1yearNN
r1mortalityNN

#Rule:Verbs
r2usedVBN
r2helpVB
r2predictVB

#Rule:Adjs
r4cardiacJJ

#Rule:Adj-Noun
r5cardiacJJeventsNNS
r55CDmortalityNN
r510CDmortalityNN

#Rule:N-HeadNoun
r8CholesterolNNlevelsNNS
r8studyNNdataNNS
r8framinghamLocationAnnotationdataNNS
r8riskNNestimationNN

#Rule:V-HeadNoun
r21isAUXfoundationNN
r21predictVBmortalityNN

#Rule:V-HeadNoun(passive)
r23usedVBNlevelsNNS

#Rule:PPinNP
r26foundationNNofINestimationNN
r26foundationNNofINtodayNN
r26estimationNNforINeventsNNS

#Rule:PPinVP
r32usedVBNwithINdataNNS

#Rule:V-V
r44usedVBNhelpVB

#Rule:V-ADV
r46isAUXessentiallyRB

#If you don t believe me (and I don t get a penny from the pharmaceutical companies who make statins, though I do prescribe them with some frequency to patients who do not meet goals for LDL levels), just look it up on medline, you will pull up literally thousands of papers on every aspect of cholesterol, cardiac disease risk, and the effect of various reduction studies - more information than you will ever be able to sort through..The
#(S1 (S (SBAR (IN If) (S (NP (PRP you)) (VP (VB don) (S (NP (NNS t)) (VP (VB believe) (S (NP (PRP me)) (PRN (-LRB- -LRB-) (S (CC and) (NP (PRP I)) (VP (VB don) (S (NP (NNS t)) (VP (VB get) (NP (DT a) (NN penny)) (PP (IN from) (NP (NP (DT the) (JJ pharmaceutical) (NNS companies)) (SBAR (WHNP (WP who)) (S (VP (VBP make) (NP (NNS statins)) (, ,) (SBAR (IN though) (S (NP (PRP I)) (VP (AUX do) (VP (VB prescribe) (NP (PRP them)) (PP (IN with) (NP (NP (DT some) (NN frequency)) (PP (TO to) (NP (NP (NNS patients)) (SBAR (WHNP (WP who)) (S (VP (AUX do) (RB not) (VP (VB meet) (NP (NP (NNS goals)) (PP (IN for) (NP (NNP LDL) (NNS levels))))))))))))))))))))))))) (-RRB- -RRB-) (, ,)) (VP (ADVP (RB just)) (VB look) (NP (PRP it)) (PRT (RP up)) (PP (IN on) (NP (NN medline)))))))))) (, ,) (NP (PRP you)) (VP (MD will) (VP (VP (VB pull) (PRT (RP up)) (NP (NP (RB literally) (NNS thousands)) (PP (IN of) (NP (NP (NNS papers)) (PP (IN on) (NP (NP (NP (DT every) (NN aspect)) (PP (IN of) (NP (NN cholesterol)))) (, ,) (NP (JJ cardiac) (NN disease) (NN risk)) (, ,) (CC and) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (JJ various) (NN reduction) (NNS studies)))))))))) (: -) (NP (NP (JJR more) (NN information)) (SBAR (IN than) (S (NP (PRP you)) (VP (MD will) (ADVP (RB ever)) (VP (AUX be) (ADJP (JJ able) (S (VP (TO to) (VP (VB sort) (PP (IN through) (NP (CD ..) (DT The))))))))))))))))
#Rule:Nouns
r1tNNS
r1tNNS
r1pennyNN
r1companiesNNS
r1statinsNNS
r1frequencyNN
r1patientsNNS
r1goalsNNS
r1LDLOrganizationAnnotation
r1levelsNNS
r1medlineNN
r1thousandsNNS
r1papersNNS
r1aspectNN
r1cholesterolNN
r1diseaseNN
r1riskNN
r1effectNN
r1reductionNN
r1studiesNNS
r1informationNN

#Rule:Verbs
r2donVB
r2believeVB
r2donVB
r2getVB
r2makeVBP
r2prescribeVB
r2meetVB
r2lookVB
r2sortVB

#Rule:V-PRT
r3lookVBupRP
r3pullVBupRP

#Rule:Adjs
r4pharmaceuticalJJ
r4cardiacJJ
r4variousJJ
r4moreJJR
r4ableJJ

#Rule:Adj-Noun
r5pharmaceuticalJJcompaniesNNS
r5cardiacJJriskNN
r5variousJJstudiesNNS
r5moreJJRinformationNN

#Rule:N-HeadNoun
r8LDLOrganizationAnnotationlevelsNNS
r8diseaseNNriskNN
r8reductionNNstudiesNNS

#Rule:N-ApposN
r10aspectNNriskNN

#Rule:HeadNoun-V
r11youPRPpullVB
r11youPRPdonVB
r11tNNSbelieveVB
r11mePRPlookVB
r11iPRPdonVB
r11tNNSgetVB
r11iPRPprescribeVB
r11youPRPbeAUX

#Rule:HeadNoun-(who/that)-V
r14companiesNNSmakeVBP
r14patientsNNSmeetVB

#Rule:V-HeadNoun
r21getVBpennyNN
r21makeVBPstatinsNNS
r21prescribeVBthemPRP
r21meetVBgoalsNNS
r21lookVBitPRP
r21pullVBinformationNN
r21pullVBthousandsNNS

#Rule:V-HeadNoun
r22donVBtNNS
r22believeVBmePRP
r22donVBtNNS

#Rule:V-ADJ
r25beAUXableJJ

#Rule:PPinNP
r26frequencyNNtoTOpatientsNNS
r26goalsNNSforINlevelsNNS
r26thousandsNNSofINpapersNNS
r26papersNNSonINaspectNN
r26papersNNSonINriskNN
r26papersNNSonINeffectNN
r26aspectNNofINcholesterolNN
r26effectNNofINstudiesNNS

#Rule:PPinVP
r30getVBfromINcompaniesNNS
r30prescribeVBwithINfrequencyNN
r30lookVBonINmedlineNN
r30sortVBthroughIN..CD

#Rule:V-IN-V
r43makeVBPthoughINprescribeVB

#Rule:V-ADV
r46doAUXnotRB
r46lookVBjustRB
r46beAUXeverRB

#There are, of course, other markers, though the most important ones you haven t mentioned.  Things like smoking history, and family history.  Homocysteine has fallen out of favor due to many causes, first it s difficult and costly to measure, but mostly because although there is evidence that shows that it does correlate to elevated CVD risk, there is not a shred of evidence that I am aware of that suggests that taking action to lower it decreases the risk, making it far less useful than cholesterol..
#(S1 (S (NP (EX There)) (VP (AUX are) (, ,) (PP (IN of) (NP (NN course))) (, ,) (NP (NP (JJ other) (NNS markers)) (, ,) (RB though) (NP (NP (DT the) (ADJP (RBS most) (JJ important)) (NNS ones)) (SBAR (S (NP (PRP you)) (VP (NN haven) (NP (NP (QP (CD t) (CD mentioned.)) (NNS Things)) (PP (IN like) (NP (NN smoking) (NN history)))))))) (, ,) (CC and) (NP (NP (NN family) (NNS history.)) (SBAR (S (NP (NNP Homocysteine)) (VP (AUX has) (VP (VBN fallen) (PRT (RP out)) (PP (IN of) (NP (NP (NN favor)) (PP (JJ due) (TO to) (NP (JJ many) (NNS causes))))) (, ,) (SBAR (RB first) (S (NP (PRP it)) (VP (VBZ s) (ADJP (JJ difficult) (CC and) (JJ costly) (SBAR (S (VP (TO to) (VP (VB measure) (PRN (, ,) (CC but) (ADVP (RB mostly))) (SBAR (IN because) (S (SBAR (IN although) (S (NP (EX there)) (VP (AUX is) (NP (NN evidence) (SBAR (IN that) (S (VP (VBZ shows) (SBAR (IN that) (S (NP (PRP it)) (VP (AUX does) (VP (VB correlate) (PP (TO to) (NP (JJ elevated) (NN CVD) (NN risk)))))))))))))) (, ,) (NP (EX there)) (VP (AUX is) (RB not) (NP (NP (DT a) (NN shred)) (PP (IN of) (NP (NN evidence) (SBAR (IN that) (S (NP (PRP I)) (VP (AUX am) (ADJP (JJ aware) (PP (IN of) (SBAR (WHNP (WDT that)) (S (VP (VBZ suggests) (SBAR (IN that) (S (VP (VBG taking) (NP (NN action)) (S (VP (TO to) (VP (VB lower) (SBAR (S (NP (PRP it)) (VP (VBZ decreases) (NP (DT the) (NN risk)) (, ,) (S (VP (VBG making) (S (NP (PRP it)) (ADJP (ADJP (RB far) (RBR less) (JJ useful)) (PP (IN than) (NP (NN cholesterol)))))))) (. .)))))))))))))))))))))))))))))))))))))) (. .)))
#Rule:Nouns
r1courseNN
r1markersNNS
r1onesNNS
r1havenNN
r1ThingsNNS
r1smokingNN
r1historyNN
r1familyNN
r1historyNNS
r1HomocysteinePersonAnnotation
r1favorNN
r1causesNNS
r1evidenceNN
r1CVDLocationAnnotation
r1riskNN
r1shredNN
r1evidenceNN
r1actionNN
r1riskNN
r1cholesterolNN

#Rule:Verbs
r2sVBZ
r2measureVB
r2showsVBZ
r2correlateVB
r2suggestsVBZ
r2takingVBG
r2lowerVB
r2decreasesVBZ
r2makingVBG

#Rule:V-PRT
r3fallenVBNoutRP

#Rule:Adjs
r4otherJJ
r4importantJJ
r4dueJJ
r4manyJJ
r4difficultJJ
r4costlyJJ
r4elevatedJJ
r4awareJJ
r4usefulJJ

#Rule:Adj-Noun
r5otherJJmarkersNNS
r5importantJJonesNNS
r5tCDThingsNNS
r5mentionedCDThingsNNS
r5manyJJcausesNNS
r5elevatedJJriskNN

#Rule:N-HeadNoun
r8smokingNNhistoryNN
r8familyNNhistoryNNS
r8CVDLocationAnnotationriskNN

#Rule:HeadNoun-V
r11thereEXareAUX
r11itPRPsVBZ
r11thereEXisAUX
r11thereEXisAUX
r11itPRPcorrelateVB
r11iPRPamAUX
r11itPRPdecreasesVBZ

#Rule:HeadNoun-V
r12HomocysteinePersonAnnotationfallenVBN

#Rule:NP(NP(z) SBAR(S(NP(x)VP(y))))
r19fallenVBNhistoryNNS

#Rule:V-HeadNoun
r21areAUXmarkersNNS
r21havenNNThingsNNS
r21isAUXevidenceNN
r21isAUXshredNN
r21takingVBGactionNN
r21decreasesVBZriskNN

#Rule:V-HeadNoun
r22makingVBGitPRP

#Rule:PPinNP
r26ThingsNNSlikeINhistoryNN
r26favorNNtoTOcausesNNS
r26shredNNofINevidenceNN

#Rule:PPinVP
r30areAUXofINcourseNN
r30correlateVBtoTOriskNN

#Rule:PPinVP
r32fallenVBNofINfavorNN

#Rule:PPinADJP
r37usefulJJthanINcholesterolNN

#Rule:V-IN-V
r43measureVBbecauseINisAUX
r43showsVBZthatINcorrelateVB
r43suggestsVBZthatINtakingVBG

#Rule:V-V
r44takingVBGlowerVB

#Rule:V-MOD
r45decreasesVBZmakingVBG

#Rule:V-ADV
r46isAUXnotRB

#CRP is another marker that has been shown to be correlated with CVD risk, and has prognostic value in certain settings, but it s unclear what interventions can be taken to lower it and whether that would make any difference.  CRP, by the way, is also very nonspecific, it s a general marker of inflammation, and may be elevated for many reasons..
#(S1 (S (S (NP (NNP CRP)) (VP (AUX is) (NP (NP (DT another) (NN marker)) (SBAR (WHNP (WDT that)) (S (VP (VP (AUX has) (VP (AUX been) (VP (VBN shown) (S (VP (TO to) (VP (AUX be) (VP (VBN correlated) (PP (IN with) (NP (JJ CVD) (NN risk)))))))))) (, ,) (CC and) (VP (AUX has) (NP (NP (JJ prognostic) (NN value)) (PP (IN in) (NP (JJ certain) (NNS settings))))))))))) (, ,) (CC but) (S (NP (PRP it)) (VP (VBZ s) (ADJP (JJ unclear) (SBAR (SBAR (WHNP (WP what)) (S (NP (NNS interventions)) (VP (MD can) (VP (AUX be) (VP (VBN taken) (S (VP (TO to) (VP (VB lower) (NP (PRP it)))))))))) (CC and) (SBAR (IN whether) (S (NP (DT that)) (VP (MD would) (VP (VB make) (S (NP (DT any) (FW difference.) (NN CRP)) (, ,) (PP (IN by) (NP (DT the) (NN way))) (, ,) (VP (AUX is) (ADVP (RB also)) (ADJP (RB very) (JJ nonspecific)) (, ,) (SBAR (S (NP (PRP it)) (VP (VP (VBZ s) (NP (NP (DT a) (JJ general) (NN marker)) (PP (IN of) (NP (NN inflammation))))) (, ,) (CC and) (VP (MD may) (VP (AUX be) (ADJP (JJ elevated) (PP (IN for) (NP (JJ many) (NNS reasons)))))))))) (. .)))))))))) (. .)))
#Rule:Nouns
r1CRPNNP
r1markerNN
r1riskNN
r1valueNN
r1settingsNNS
r1interventionsNNS
r1CRPNN
r1wayNN
r1markerNN
r1inflammationNN
r1reasonsNNS

#Rule:Verbs
r2shownVBN
r2correlatedVBN
r2sVBZ
r2takenVBN
r2lowerVB
r2makeVB
r2sVBZ

#Rule:Adjs
r4CVDOrganizationAnnotation
r4prognosticJJ
r4certainJJ
r4unclearJJ
r4nonspecificJJ
r4generalJJ
r4elevatedJJ
r4manyJJ

#Rule:Adj-Noun
r5CVDOrganizationAnnotationriskNN
r5prognosticJJvalueNN
r5certainJJsettingsNNS
r5generalJJmarkerNN
r5manyJJreasonsNNS

#Rule:HeadNoun-V
r11CRPNNPisAUX
r11itPRPsVBZ
r11thatDTmakeVB
r11CRPNNisAUX
r11itPRPsVBZ
r11itPRPbeAUX

#Rule:HeadNoun-(who/that)-V
r14markerNNhasAUX

#Rule:V-(who/that)-HeadNoun
r18shownVBNmarkerNN

#Rule:V-HeadNoun
r21isAUXmarkerNN
r21hasAUXvalueNN
r21lowerVBitPRP
r21sVBZmarkerNN

#Rule:V-HeadNoun
r22makeVBCRPNN

#Rule:V-HeadNoun(passive)
r23takenVBNinterventionsNNS

#Rule:V-ADJ
r25isAUXnonspecificJJ
r25beAUXelevatedJJ

#Rule:PPinNP
r26valueNNinINsettingsNNS
r26markerNNofINinflammationNN

#Rule:PPinVP
r32correlatedVBNwithINriskNN

#Rule:PPinS
r36isAUXbyINwayNN

#Rule:PPinADJP
r37elevatedJJforINreasonsNNS

#Rule:V-V
r44takenVBNlowerVB

#Rule:V-ADV
r46isAUXalsoRB

#Rule:IS-RULE
r47markerNNCRPNNP

#There are several lipoproteins that have been looked at as potential markers, but none have really panned out (yet) as reliable, practical markers, research is ongoing, but I m not sure exactly what you re referring to when you say lipoprotein.
#(S1 (S (S (NP (EX There)) (VP (AUX are) (NP (NP (JJ several) (NNS lipoproteins)) (SBAR (WHNP (WDT that)) (S (S (VP (AUX have) (VP (AUX been) (VP (VBN looked) (PP (IN at) (NP (RB as) (JJ potential) (NNS markers))))))) (, ,) (CC but) (S (NP (NN none)) (VP (AUX have) (ADVP (RB really)) (VP (VBN panned) (PRT (RP out)) (PRN (-LRB- -LRB-) (ADVP (RB yet)) (-RRB- -RRB-)) (PP (IN as) (NP (JJ reliable) (, ,) (JJ practical) (NNS markers))))))))))) (, ,) (S (NP (NN research)) (VP (AUX is) (ADJP (JJ ongoing)))) (, ,) (CC but) (S (NP (PRP I)) (VP (NNP m) (SBAR (ADVP (RB not) (RB sure) (RB exactly)) (WHNP (WP what)) (S (NP (PRP you) (NNP re)) (VP (VBG referring) (PP (TO to) (SBAR (WHADVP (WRB when)) (S (NP (PRP you)) (VP (VBP say) (NP (NN lipoprotein))))))))))) (. .)))
#Rule:Nouns
r1lipoproteinsNNS
r1markersNNS
r1noneNN
r1markersNNS
r1researchNN
r1mNNP
r1reNNP
r1lipoproteinNN

#Rule:Verbs
r2lookedVBN
r2referringVBG
r2sayVBP

#Rule:V-PRT
r3pannedVBNoutRP

#Rule:Adjs
r4severalJJ
r4potentialJJ
r4reliableJJ
r4practicalJJ
r4ongoingJJ

#Rule:Adj-Noun
r5severalJJlipoproteinsNNS
r5potentialJJmarkersNNS
r5reliableJJmarkersNNS
r5practicalJJmarkersNNS

#Rule:HeadNoun-V
r11thereEXareAUX
r11researchNNisAUX
r11reNNPreferringVBG
r11youPRPsayVBP

#Rule:HeadNoun-V
r12noneNNpannedVBN

#Rule:V-HeadNoun
r21areAUXlipoproteinsNNS
r21sayVBPlipoproteinNN

#Rule:V-ADJ
r25isAUXongoingJJ

#Rule:PPinVP
r32lookedVBNatINmarkersNNS
r32pannedVBNasINmarkersNNS

#Rule:V-ADV
r46haveAUXreallyRB
r46pannedVBNreallyRB

@lemmas-left	reliable	lower	don	reason	prescribe	people	course	time	help	are	refer	levels	event	correlated	doctors	year	thousands	Things	information	inflammation	heart	shown	companies	papers	suggest	Cholesterol	meet	shows	goal	include	many	aspect	statin	5	say	favor	counts	pharmaceutical	panned	attacks	we	hospitalization	lipoproteins	sort	referring	simple	events	data	mentioned	use	reasons	difficult	interested	CVD	patients	patient	intervention	smoking	do	me	foundation	correlate	trial	want	look	haven	longer.	back	rates	us	m	history.	helps	ones	research	taking	i	history	10	cardiac	including	t	s	predict	mentioned.	fall	mortality	unclear	healthy	cardiovascular	attack	nonspecific	decrease	Homocysteine	keep	shred	cause	count	pull	settings	CRP	statins	aware	show	study	framingham	rates.	alive	used	studies	has	doctor	backs	lipoprotein	more	level	practical	fallen	family	value	action	none	useful	longer	taken	reduction	trials	be	suggests	get	markers	controlled	cholesterol	reduce	that	lowering	prognostic	marker	decreases	company	several	due	penny	causes	make	large	elevated	treat	other	medline	measure	have	estimation	one	evidence	way	today	frequency	re	disease	believe	setting	risk	LDL	able	making	various	is	it	crp	interventions	important	potential	you	thousand	know	general	pan	goals	ongoing	effect	looked	take	there	certain	things	costly	
@lemmas-right	they	lower	don	reason	prescribe	hopefully	people	course	help	time	are	refer	levels	event	doctors	thousands	Things	information	inflammation	shown	companies	papers	meet	goal	not	aspect	statin	them	say	favor	counts	panned	attacks	hospitalization	lipoproteins	referring	simple	events	data	reasons	interested	patients	patient	intervention	foundation	me	correlate	trial	want	look	just	back	longer.	us	rates	helps	history.	ones	taking	essentially	up	history	really	t	s	fall	mortality	attack	nonspecific	decrease	shred	cause	count	pull	CRP	settings	statins	show	study	rates.	studies	has	backs	doctor	lipoprotein	level	fallen	..	value	action	longer	trials	be	get	markers	cholesterol	reduce	that	marker	decreases	better	company	penny	make	causes	ever	elevated	treat	medline	have	estimation	evidence	one	way	today	frequency	disease	believe	setting	risk	able	making	is	it	crp	interventions	thousand	know	pan	goals	ongoing	effect	take	am	things	also	out	
@lemmas-center	to	with	for	at	as	by	from	through	like	in	though	because	of	that	than	on	